Influence of new γ-hydroxybutyric acid amide analogues on the central nervous system activity in mice

Polish Journal of Pharmacology

Volumn 54, Issue 6, 2002, Pages 731-736

  Sałat, Kinga ^a   Mendyk, Anna ^a   Librowski, Tadeusz ^a   Czarnecki, Ryszard ^a   Malawska, Barbara ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Gamma hydroxybutyric acid; Mice; Pentetrazole; Picrotoxin; Thiopental induced sleep

Indexed keywords

4 HYDROXYBUTYRIC ACID; 4 HYDROXYBUTYRIC ACID DERIVATIVE; AMIDE; ANTICONVULSIVE AGENT; BM 68; BM 74; BM 75; BM 76; DIAZEPAM; DRUG VEHICLE; ETHOSUXIMIDE; METHYLCELLULOSE; PENTETRAZOLE; PICROTOXIN; SODIUM CHLORIDE; THIOPENTAL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; IN VIVO STUDY; MALE; MORTALITY; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; SEIZURE; SLEEP INDUCTION; SUSPENSION;

ANIMALS; CENTRAL NERVOUS SYSTEM; GAMMA-AMINOBUTYRIC ACID; HYDROXYBUTYRATES; MALE; MICE; SEIZURES; SLEEP;

EID: 0036968741     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Addolorato G., Balducci G., Capristo E.: Gamma-hydroxybutyric acid in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Alcohol-Clin. Exp. Res., 1999, 23, 1596-1604.
2. Addolorato G., Cibin M., Caputo F.: Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients. Drug Alcohol Dependence, 1998, 53, 7-10.
3. Hu R.Q., Banerjee P.K., Snead O.C.: Regulation of gamma-aminobutyric acid release in cerebral cortex in the gamma-hydroxybutyric acid model of absence seizures in rat. Neuropharmacology, 2000, 39, 427-439.
4. Kupferbeger H.: Antiepileptic drug development program. A cooperative effort of government and industry, Epilepsia, 1989, 30, Suppl. 1, 51-56.
5. Maitre M., Hechler V., Vayer P., Gobaille S., Cash C., Schmitt M., Bourguignon J.: A specific γ-hydroxybutyrate receptor ligand possess both antagonistic and anticonvulsant properties. J. Pharmacol. Exp. Ther., 1990, 255, 657-663.
6. Malawska B.: Searching of γ-amino- and γ-hydroxybutyric acid analogues with expected anticonvulsant activity (Polish). Wiad. Chem., 2001, 55, 377-402.
7. Malawska B., Kulig K., Antkiewicz-Michaluk L., Cliffe I., Porter R., Misra A.: Anticonvulsant activities and voltage-sensitive calcium channels receptor affinity of substituted N-benzylamides of γ-amino- and γ-hydroxybutyric acid. Arch. Pharm. Pharm. Med. Chem., 1999, 332, 167-174.
8. Mazzetti di Pietralata M., Florentino, M. T.: Night eating syndrome. Preliminary results. Eat Weight Disord. 2000, 5, 92-101.
9. Przewłocka B., Lasoń W.: Epilepsy: mechanisms and pharmacotherapy (Polish). XV Winter School of the Institute of Pharmacology, Polish Academy of Sciences, Mogilany, Kraków, 1998.
10. Ramek. M.: Intramolecular hydrogen bonds in hydroxy acids. J. Mol. Struct. (Theochem), 1994, 310, 269-278.
11. Snead O.C.: γ-Hydroxybutyrate. Life Sci., 1977, 20, 1935-1943.
12. Snead O.C.: Gamma-hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models. Epilepsia 1998, 29, 361-368.
13. Snead O.C, Hechler V., Vergnes M., Maitre M.: Increased γ-hydroxybutyric acid receptors in thalamus of genetic animal model of petit mal epilepsy. Epilepsy Res., 1990, 7, 121-128.
14. Stevens G., Zingel V.: Progress in Drug Research. Birkhauser Verlag, Basel, Boston, Berlin, 1995.
15. Tunnicliff G.: Significance of γ-hydroxybutyric acid in the brain. Gen. Pharmacol., 1992, 23, 1027-1034.
16. Tunnicliff G.: Sites of action of gamma-hydroxybutyrate (GHB) - a neuroactive drug with abuse potential. J. Toxicol. Clin. Toxicol., 1997, 35, 581-590.
17. Vayer P., Mandel P., Maitre M.: γ-Hydroxybutyrate: a possible neurotransmitter. Life Sci., 1987, 41, 1547-1557.